Skip Navigation


JAC Advance Access originally published online on March 29, 2008
Journal of Antimicrobial Chemotherapy 2008 62(1):205-206; doi:10.1093/jac/dkn132
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
62/1/205    most recent
dkn132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Torres-Rodríguez, J. M.
Right arrow Articles by Sellart, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres-Rodríguez, J. M.
Right arrow Articles by Sellart, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Research letters

MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii

Josep M. Torres-Rodríguez1,2,*, Eidi Alvarado-Ramírez1,2, Francisca Murciano1 and Maite Sellart1,2

1 Infectious Disease and Mycology Research Unit, Institut Municipal d'Investigació Mèdica, Parc de Recerca Biomèdica de Barcelona, Dr Aiguader 88, 08003 Barcelona, Spain 2 UDIMAS, Autonomous University of Barcelona, Dr Aiguader 80, 08003 Barcelona, Spain

* Correspondence address. Infectious Disease and Mycology Research Unit, Institut Municipal d'Investigació Mèdica, Parc de Recerca Biomèdica de Barcelona, Dr Aiguader 88, Barcelona 08003, Spain. Tel: +34-933160400; Fax: +34-933160410; E-mail: jmtorres@imim.es

Keywords: antifungals , triazoles , yeast , in vitro susceptibility

The first 10% of the full text of this article appears below.

Sir,

The major aetiological species of cryptococcosis is Cryptococcus neoformans, which is distributed especially in association with pigeon droppings, and the most common infection is in the CNS of immunocompromised patients. Cryptococcus gattii, previously considered a biovariety of C. neoformans, is the second agent of cryptococcosis; four basic serotypes have been described: A and D for C. neoformans and B and C for C. gattii. Although its geographical distribution is restricted, C. gattii is being reported in new areas and has produced epidemic outbreaks . . . [Full Text of this Article]


   Funding
 

   Transparency declarations
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?